A genomic medicine expertise company based in Finland offers an easy-to-read, medical professional approved interpretation service on pharmacogenetic test results to help clinicians, laboratories and consumers to understand and benefit from the complex pharmacogenetic data. Their solution, the Pharmacogenetic (PGx) Interpretation Service, interprets the complex pharmacogenetic data and offers reliable and easy to understand PGx's state-of-the-art reports on pharmacogenetic test results. The service covers around 20 genes, that affect more than 120 drug substances, giving individual dosing recommendations for each drug. The reports are available in Finnish, English, German and Swedish, and can be quickly translated into any languages upon customer needs.
The company has also launched a pharmacogenetic testing kit for customer use. Customer can do the buccal swab test at home or at pharmacy/doctor's office and the kit can be easily mailed to laboratory. The interpreted results including individual dosing recommendations for over 120 drug substances is provided for customer in easy-to-read report format, stored in secured cloud-based web services.
The SME was established in 2013 and it has a strong medical competence inhouse. The SME is growing fast, and they are now expanding to new markets.
Drug safety and effectiveness are determined to a large extent by the person's individual genotype. Pharmacogenetic testing can be used pre-emptively when prescribing a drug and determining the right drug and dosage.
One of the most important genes in pharmacogenetics is CYP2D6. Approximately a quarter of all drugs prescribed annually metabolize through this liver enzyme. These drugs include e.g. opioids, antidepressants, and cardiac arrhythmia medicine. Depending on their genotype people can be divided in three groups based on their CYP2D6 activity: normal, rapid and slow drug metabolizers. Prescribing standard dose for a rapid metabolizer leads to an inefficiency of the treatment, and poor metabolizer faces problems as drug accumulates in the bloodstream. Pharmacogenetic testing is essential, when it comes determining the right dosage of these kind of drugs. The test increases not only individual's wellbeing, but also creates significant savings in healthcare costs.
The company is searching for university laboratories or other clinical laboratories to serve them under service agreements in pharmacogenetic interpretation.
The company also searching corporate partners and distributors for their new buccal swab test kit. Pharmacy chains are the most suitable distributors for this product.